Mary J. Laughlin, M.D., established the Cleveland Cord Blood Center (CCBC) in 2008 in conjunction with the growing role of stem-cell rich umbilical cord blood for transplantation in patients with life-threatening disorders such as leukemia, lymphoma and immune system disorders. Dr. Laughlin, who performed one of the world’s first successful umbilical cord blood stem cell transplants on an adult leukemia patient in 1995, launched the public cord blood bank with the commitment to serve the unmet needs of a diverse population.
Since its establishment, the Cleveland Cord Blood Center has become:
- A leader in the collection, processing, storage and distribution of quality cord blood stem cell units
- A researcher in the exploration of umbilical cord blood’s expanding potential as a cell therapy treatment
- An innovator in the field of umbilical cord blood cellular therapy initiatives
- A prominent player in fostering greater awareness of the life-giving and lifesaving potential that cord blood stem cells hold